Mo1053 A Phase 2, Randomized, Double-Blind, Parallel-Group, Multicenter, Dose-Ranging Study to Evaluate the Efficacy and Safety of a Novel Potassium-Competitive Acid Blocker (P-CAB) TAK-438 in Patients With Erosive Esophagitis
Chiba, Tsutomu, Sakurai, Yuuichi, Nishimura, Akira, Hiramatsu, Naoki, Umegaki, Eiji, Iwakiri, Katsuhiko, Ashida, KiyoshiVolume:
144
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(13)62088-0
Date:
May, 2013
File:
PDF, 325 KB
english, 2013